Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (31-40 of 386) with videos related to

Pageof 39
Sort By:
Journal of Clinical Medicine|June 27, 2015
Rational Combinations of Targeted Agents in AMLPrithviraj Bose, Steven Grant
Current Oncology Reports|January 31, 2004
Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agentsYun Dai, Steven Grant
Best Practice & Research. Clinical Haematology|June 13, 2012
Proteasome inhibitors in mantle cell lymphomaBeata Holkova, Steven Grant
British Journal of Nursing (Mark Allen Publishing)|May 23, 2026
The STEPs educational framework for medicines management: using mnemonics to reduce harmSteven Grant, Claire Sutton
Advances in Cancer Research|October 24, 2012
Histone deacetylase inhibitors and rational combination therapiesSteven Grant, Yun Dai
Cancer Biology & Therapy|March 23, 2006
CDK inhibitor targets: a hit or miss proposition?: cyclin-dependent kinase inhibitors kill tumor cells by downregulation of anti-apoptotic proteinsYun Dai, Steven Grant
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
New insights into checkpoint kinase 1 in the DNA damage response signaling networkYun Dai, Steven Grant
Cell Cycle (Georgetown, Tex.)|January 28, 2003
Conversion of drug-induced differentiation to apoptosis by pharmacologic cyclin-dependent kinase inhibitorsSteven Grant, Paul Dent
Molecular Cancer Therapeutics|July 15, 2004
Gene profiling and the cyclin-dependent kinase inhibitor flavopiridol: what's in a name?Steven Grant, Paul Dent
Cell Cycle (Georgetown, Tex.)|March 19, 2010
Targeting Chk1 in the replicative stress responseYun Dai, Steven Grant
Pageof 39

Showing results (31-40 of 386) with videos related to

Sort By:
Pageof 39
Journal of Clinical Medicine|June 27, 2015
Rational Combinations of Targeted Agents in AMLPrithviraj Bose, Steven Grant
Current Oncology Reports|January 31, 2004
Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agentsYun Dai, Steven Grant
Best Practice & Research. Clinical Haematology|June 13, 2012
Proteasome inhibitors in mantle cell lymphomaBeata Holkova, Steven Grant
British Journal of Nursing (Mark Allen Publishing)|May 23, 2026
The STEPs educational framework for medicines management: using mnemonics to reduce harmSteven Grant, Claire Sutton
Advances in Cancer Research|October 24, 2012
Histone deacetylase inhibitors and rational combination therapiesSteven Grant, Yun Dai
Cancer Biology & Therapy|March 23, 2006
CDK inhibitor targets: a hit or miss proposition?: cyclin-dependent kinase inhibitors kill tumor cells by downregulation of anti-apoptotic proteinsYun Dai, Steven Grant
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
New insights into checkpoint kinase 1 in the DNA damage response signaling networkYun Dai, Steven Grant
Cell Cycle (Georgetown, Tex.)|January 28, 2003
Conversion of drug-induced differentiation to apoptosis by pharmacologic cyclin-dependent kinase inhibitorsSteven Grant, Paul Dent
Molecular Cancer Therapeutics|July 15, 2004
Gene profiling and the cyclin-dependent kinase inhibitor flavopiridol: what's in a name?Steven Grant, Paul Dent
Cell Cycle (Georgetown, Tex.)|March 19, 2010
Targeting Chk1 in the replicative stress responseYun Dai, Steven Grant
Pageof 39